Smith & Nephew

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Smith & Nephew and other ETFs, options, and stocks.

About SNN

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. 

CEO
Deepak S Nath
CEODeepak S Nath
Employees
18,456
Employees18,456
Headquarters
Watford, Herefordshire
HeadquartersWatford, Herefordshire
Founded
1856
Founded1856
Employees
18,456
Employees18,456

SNN Key Statistics

Market cap
14.80B
Market cap14.80B
Price-Earnings ratio
25.16
Price-Earnings ratio25.16
Dividend yield
2.01%
Dividend yield2.01%
Average volume
917.27K
Average volume917.27K
High today
$35.52
High today$35.52
Low today
$34.58
Low today$34.58
Open price
$34.87
Open price$34.87
Volume
1.80M
Volume1.80M
52 Week high
$38.79
52 Week high$38.79
52 Week low
$23.91
52 Week low$23.91

SNN News

TipRanks 11h
Smith+Nephew CEO Deepak Nath to Join Reckitt Board as Independent Director

Smith & Nephew Snats ( (SNN) ) has issued an update. Smith+Nephew has disclosed that its Chief Executive Officer, Deepak Nath, will join the board of consumer...

TipRanks 14h
Smith & Nephew price target raised to $35 from $34 at Canaccord

Canaccord raised the firm’s price target on Smith & Nephew to $35 from $34 and keeps a Hold rating on the shares. The firm said they delivered a solid quarter,...

TipRanks 2d
Smith & Nephew price target raised to 1,305 GBp from 1,290 GBp at Barclays

Barclays raised the firm’s price target on Smith & Nephew to 1,305 GBp from 1,290 GBp and keeps an Equal Weight rating on the shares. Published first on TheFly...

Analyst ratings

69%

of 16 ratings
Buy
31.3%
Hold
68.8%
Sell
0%

More SNN News

TipRanks 3d
Smith & Nephew Earnings Call Highlights Profitable Momentum

Smith & Nephew Snats ((SNN)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium Unlock hedge fund-level...

TipRanks 3d
Smith & Nephew Updates Voting Share Capital and Rights as of 28 February 2026

An announcement from Smith & Nephew Snats ( (SNN) ) is now available. As of 28 February 2026, Smith & Nephew plc reported total issued share capital of 877,724...

TipRanks 3d
Smith+Nephew Posts Strong 2025 Results, Completes Transformation and Sets 2026 Growth Targets

Smith & Nephew Snats ( (SNN) ) has issued an update. Smith+Nephew reported a strong finish to 2025, with fourth-quarter revenue rising to $1.70 billion and ful...

TipRanks 3d
Smith & Nephew: Resilient Fundamentals and Earnings Momentum Support Buy Rating

Analyst Aisyah Noor of Morgan Stanley maintained a Buy rating on Smith & Nephew, retaining the price target of p1,482.00. Aisyah Noor has given his Buy rating...

Nasdaq 4d
Smith & Nephew FY25 Results Rise, Lifts Dividend; Sees Growth Ahead

(RTTNews) - Smith & Nephew Plc (SNN, SN.L), a British medical technology company, reported Monday significantly higher profit in fiscal 2025, with increased rev...

Smith & Nephew FY25 Results Rise, Lifts Dividend; Sees Growth Ahead

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.